Argatroban

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

20 Suppliers, 10 USDMF, 6 JDMF, 2 EU WC, 2 KDMF, 6 NDC API, 7 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

3 Suppliers

3 Suppliers

DOSSIERs // Finished Dosage Forms

26 Dossiers, 19 FDA Orange Book, 2 Europe, 1 Canada, 4 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML), INJECTABLE;INJECTION - 50MG/50ML (1MG/ML), INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML), INJECTABLE;INTRAVENOUS - 50MG/50ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - 125MG/125ML (1MG/ML)

RELATED EXCIPIENT COMPANIES

Suppliers, 11 Roquette, 2 Actylis, 2 DKSH, 2 SPI Pharma, 2 Nanjing Well Pharmaceutical, 1 BASF, 1 Finar, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Rochem International Inc, 1 Zhejiang Huakang Pharmaceutical, 1 Gangwal Healthcare

EXCIPIENTS BY APPLICATIONS

11 Film Formers & Plasticizers, 6 Fillers, Diluents & Binders, 6 Parenteral, 4 Taste Masking, 4 Coating Systems & Additives, 3 Topical, 2 Chewable & Orodispersible Aids, 1 Co-Processed Excipients, 1 Direct Compression, 1 Soft Gelatin, 1 Solubilizers, 1 Thickeners and Stabilizers

GLOBAL SALES INFORMATION

2 Finished Drug Prices

2 Finished Drug Prices

MARKET PLACE

2 APIs

2 APIs

PATENTS

2 US Patents

2 US Patents

ANALYTICAL SOLUTION(s)

2 USP Standards, 6 Other Ref. Standards

DIGITAL CONTENT

2 Data Compilation & Company Tracker #PharmaFlow, 9 News

Information, Expiry & Status of FDA Orange Book Patents covering Argatroban

Argatroban

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

20 Suppliers

10 USDMF

6 JDMF

2 EU WC

2 KDMF

6 NDC API

7 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

INTERMEDIATES

3 Suppliers

DOSSIERs // Finished Dosage Forms

26 Dossiers

19 FDA Orange Book

2 Europe

1 Canada

4 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML)

INJECTABLE;INJECTION - 50MG/50ML (1MG/ML)

INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML)

INJECTABLE;INTRAVENOUS - 50MG/50ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INTRAVENOUS - 125MG/125ML (1MG/ML)

RELATED EXCIPIENT COMPANIES

Suppliers

11 Roquette

2 Actylis

2 DKSH

2 SPI Pharma

2 Nanjing Well Pharmaceutical

1 BASF

1 Finar

1 Shijiazhuang Huaxu Pharmaceutical

1 Rochem International Inc

1 Zhejiang Huakang Pharmaceutical

1 Gangwal Healthcare

EXCIPIENTS BY APPLICATIONS

11 Film Formers & Plasticizers

6 Fillers, Diluents & Binders

6 Parenteral

4 Taste Masking

4 Coating Systems & Additives

3 Topical

2 Chewable & Orodispersible Aids

1 Co-Processed Excipients

1 Direct Compression

1 Soft Gelatin

1 Solubilizers

1 Thickeners and Stabilizers

GLOBAL SALES INFORMATION

2 Finished Drug Prices

MARKET PLACE

2 APIs

PATENTS

2 US Patents

ANALYTICAL SOLUTION(s)

2 USP Standards

6 Other Ref. Standards

DIGITAL CONTENT

2 Data Compilation & Company Tracker #PharmaFlow

9 News

Argatroban

CIPLA

ARGATROBAN

7687516

Y

2027-09-26

U-1164

22434

METHOD OF TREATING AN ARGATROBAN TREATABLE CONDITION

INJECTABLE;INTRAVENOUS - 50MG/50ML (1MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons